bpc-157 interstitial cystitis pilot study / GLX-100 BPC-157 as an Investigational Peptide

The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]

You can try to use your primary care physician as long as you use the recommended settings above but beware: Most physicians are not used to dosing vitamins and are very unfamiliar with them in general

10.1212/WNL.0000000000000623 83

Researchers have examined BPC-157 in the context of wound-healing biology, soft-tissue regeneration models, and nitric oxide pathway modulation, making it a versatile tool compound in pharmacological and physiological research programs